Sign in
Knowstox

Fundamentals snapshot

Cresco Labs Inc.

CRLBF · OQX · Healthcare · Drug Manufacturers - Specialty & Generic

Current price

$0.61

52-week range

$0.57 - $2.30

Market cap

$226.81M

One-glance verdict

Overvalued

$-0.09 our estimate vs market $0.61

Wall Street consensus: $2.00 (-2,380.6% lower than our fair-value estimate)

Balance sheet

Stretched

1.28x Concerning

Net debt $559.15M. Interest coverage shows how many times profit covers the interest bill.

What this company does

Cresco Labs Inc.

Cresco Labs sells various cannabis products like flowers and vape pens across the US and Germany, with most of its money coming from these sales. This matters because the company is a significant player in the growing cannabis market, and its sales performance shows how well it’s doing in that space.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q4 $112.99M FY2025 Q4 $37.75M
Revenue $655.85M
Net income $-135.41M
Diluted EPS -0.38
Operating cash flow $72.89M
Free cash flow $37.75M
Revenue $724.34M
Net income $-74.44M
Diluted EPS -0.22
Operating cash flow $132.48M
Free cash flow $112.99M

Is it cheap or expensive?

Fair value $-0.09 vs current price $0.61

Wall Street consensus is the average analyst price target: $2.00 (-2,380.6% lower than our fair-value estimate).

Our most-likely fair value is $-0.09 a share — about 114.3% below today's price of $0.61, so the stock currently looks expensive (overvalued).

overvalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 8.0% · Discount 11.8% · Terminal 3.0%

$-0.09

Bear

Growth 3.0% · Discount 11.8% · Terminal 3.0%

$-0.44

Bull

Growth 15.0% · Discount 11.8% · Terminal 3.0%

$0.57

Is it drowning in debt?

Stretched

Net debt $559.1M. Interest coverage 1.3x.

Net debt $559.15M
Interest coverage 1.28x

Cresco Labs Inc. is healthier than 0 of 1 peers on balance-sheet leverage.

Stretched
Worse cushion Baseline Better cushion
CRLBF BASELINE Cresco Labs Inc.

Total debt $592.02M Interest coverage 1.28x This is the baseline the peer rows are being compared against.

1.28x

What you should know

The case for and against CRLBF

1 Reward 1 Risk

Rewards

  • Free cash flow was positive in 3/10 years.

Risks

  • Return on equity was -36.1% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
-15.32x
P/B
0.64x
P/S
0.35x
EV/EBITDA
6.23x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
49.9%
Operating margin
7.7%
Net margin
-15.5%
ROE
-36.1%
ROA
3.0%

Health

Liquidity and balance-sheet strength

Debt / equity
2.25x
Current ratio
1.78x
Quick ratio
0.53x
Total debt
$592.02M
Total cash
$32.87M

Growth

How the business has been compounding

Revenue TTM
$655.85M
Revenue 5Y CAGR
-9.5%
EPS TTM
-0.38
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$72.89M
Free CF TTM
$34.71M
FCF margin
5.3%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—